Literature DB >> 10891619

Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry.

N Singewald1, T Sharp.   

Abstract

It is speculated that specific hindbrain transmitter pathways centred on the periaqueductal gray and locus coeruleus are an important integrative neural substrate for the expression of anxiety and the somatic symptoms and cardiovascular changes that accompany severe anxiety states, such as in panic disorder. Here we investigated the effects of various drugs, known to induce panic in humans and to be anxiogenic in animals, on Fos expression in the periaqueductal gray, locus coeruleus and other parts of the rat hindbrain. The drugs tested were the benozodiazepine inverse agonist FG-7142, the alpha(2)-adrenoceptor antagonist yohimbine, the non-selective 5-hydroxytryptamine(2C) receptor agonist m-chlorophenyl piperazine, the adenosine antagonist caffeine and the cholecystokinin analogue BOC-CCK(4). A clear-cut finding was that administration of each anxiogenic drug caused a striking region-specific pattern of Fos expression within the hindbrain. In particular, the drugs commonly increased Fos-like immunoreactivity in the periaqueductal gray and locus coeruleus. Increased Fos expression in the periaqueductal gray was specific to the rostral dorsolateral and caudal ventrolateral regions. All the anxiogenic drugs also increased Fos-like immunoreactivity in the lateral parabrachial nucleus and nucleus of the solitary tract and all but one (BOC-CCK(4)) increased Fos in the dorsal raphe nucleus. Rats habituated to the test environment and injected with saline vehicle displayed little or no Fos-like immunoreactivity in the hindbrain areas investigated. In summary, each of the anxiogenic drugs tested (FG-7142, yohimbine, m-chlorophenyl piperazine, caffeine and BOC-CCK(4)) increased Fos expression in a restricted number of hindbrain regions, including the periaqueductal gray and locus coeruleus. Previous Fos studies have found that these same regions are activated by various fearful environmental stimuli. Therefore, a specific set of hindbrain circuits may be commonly involved in the processing of anxiety-related information evoked by pharmacological and environmental manipulation. The present findings also raise the possibility that measurement of the effect of anxiogenic drugs on Fos expression might be a useful way to model hindbrain pathways activated by anxiety and possibly panic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891619     DOI: 10.1016/s0306-4522(00)00177-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  32 in total

1.  GABAA receptor signaling in caudal periaqueductal gray regulates maternal aggression and maternal care in mice.

Authors:  Grace Lee; Stephen C Gammie
Journal:  Behav Brain Res       Date:  2010-05-08       Impact factor: 3.332

2.  Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs.

Authors:  B E H Sumner; L A Cruise; D A Slattery; D R Hill; M Shahid; B Henry
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

3.  Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures.

Authors:  Kelly S Sink; David L Walker; Yong Yang; Michael Davis
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

4.  Effects of chronic caffeine exposure during adolescence and subsequent acute caffeine challenge during adulthood on rat brain serotonergic systems.

Authors:  M R Arnold; P H Williams; J A McArthur; A R Archuleta; C E O'Neill; J E Hassell; D G Smith; R K Bachtell; C A Lowry
Journal:  Neuropharmacology       Date:  2018-12-20       Impact factor: 5.250

5.  Exposure to an open-field arena increases c-Fos expression in a subpopulation of neurons in the dorsal raphe nucleus, including neurons projecting to the basolateral amygdaloid complex.

Authors:  M W Hale; A Hay-Schmidt; J D Mikkelsen; B Poulsen; J A Bouwknecht; A K Evans; C E Stamper; A Shekhar; C A Lowry
Journal:  Neuroscience       Date:  2008-10-04       Impact factor: 3.590

6.  Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise.

Authors:  Benjamin N Greenwood; Paul V Strong; Leah Brooks; Monika Fleshner
Journal:  Psychopharmacology (Berl)       Date:  2008-05-03       Impact factor: 4.530

7.  Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels.

Authors:  Martina J Sinnegger-Brauns; Alfred Hetzenauer; Irene G Huber; Erik Renström; Georg Wietzorrek; Stanislav Berjukov; Maurizio Cavalli; Doris Walter; Alexandra Koschak; Ralph Waldschütz; Steffen Hering; Sergio Bova; Patrik Rorsman; Olaf Pongs; Nicolas Singewald; Jörg Striessnig
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

8.  Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats.

Authors:  Daniele C Aguiar; Ana Luisa B Terzian; Francisco S Guimarães; Fabrício A Moreira
Journal:  Psychopharmacology (Berl)       Date:  2009-04-22       Impact factor: 4.530

9.  Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice.

Authors:  Ngoc Khoi Nguyen; Simone B Sartori; Herbert Herzog; Ramon Tasan; Günther Sperk; Nicolas Singewald
Journal:  Synapse       Date:  2009-03       Impact factor: 2.562

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.